Construction of the Biologics Manufacturing Centre was completed in June 2021, and following an inspection in July 2022, Health Canada issued the facility's drug establishment licence in August 2022.
What does it take to make a facility like the Biologics Manufacturing Centre compliant with good manufacturing practices (GMP) and therefore eligible for a drug establishment licence?
To help answer this question, we've put the spotlight on what and who is inside the Biologics Manufacturing Centre, and outlined some of literally thousands of steps—some small, some massive—required to make a new GMP‑compliant facility ready for licensing and for making a new vaccine—at the same time.
